Stock TBIO TELESIS BIO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Telesis Bio, Inc.

Equities

TBIO

US1920032000

Real-time Estimate Cboe BZX
Other stock markets
 01:01:45 2024-05-21 pm EDT 		5-day change 1st Jan Change
4.53 USD +0.44% Intraday chart for Telesis Bio, Inc. +7.95% -36.65%
May. 09 Earnings Flash (TBIO) TELESIS BIO Reports Q1 Revenue $3.4M MT
May. 09 Telesis Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Telesis Bio: Q1 Earnings Snapshot
AQ
Telesis Bio Reports First Quarter 2024 Financial Results
GL
Telesis Bio Announces Reverse Stock Split
GL
Telesis Bio Inc. announces strategic focus on game-changing Gibson SOLA enzymatic DNA synthesis (EDS) platform and BioXp mRNA solutions and announces new leadership
GL
Telesis Bio : Shareholder Meeting - Form 8-K
PU
Telesis Bio: Q4 Earnings Snapshot
AQ
Telesis Bio Reports Fourth Quarter and Full Year 2023 Financial Results
GL
Stocks Making Waves: Insights into Key Developments and Potential VTAK, TBIO, OCEA, ONMD, KZIA
AQ
Telesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial Results
GL
Telesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial Results
AQ
Thinking about buying stock in Telesis Bio, Sellas Life Sciences, Mitek Systems, Monopar Therapeutics, or Inpixon?
PR
Telesis Bio Reports Third Quarter 2023 Financial Results
GL
Telesis Bio Reports Third Quarter 2023 Financial Results
AQ
Telesis Bio to Report Third Quarter Financial Results on Monday, November 13, 2023
GL
Telesis Bio Announces Commercial Release of Cell-free Amplification Kit for Generation of Transfection-scale DNA
GL
Telesis Bio Announces Commercial Release of Cell-free Amplification Kit for Generation of Transfection-scale DNA
AQ
Telesis Bio Announces Commercial Release of BioXp® NGS Library Prep Kit for WGS
GL
Telesis Bio Appoints William J. Kullback Chief Financial Officer
GL
Telesis Bio Appoints William J. Kullback Chief Financial Officer
AQ
Telesis Bio Reports Second Quarter 2023 Financial Results
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TBIO Stock
  4. News Telesis Bio, Inc.
  5. Press Releases
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW